Tech Company Financing Transactions
Neurosoft Bioelectronics Funding Round
Neurosoft Bioelectronics secured a $7.5 million Seed funding round on 5/20/2026. Investors included Skybound Capital, Connecticut Innovations and IAG Capital Partners.
Transaction Overview
Company Name
Announced On
5/20/2026
Transaction Type
Venture Equity
Amount
$7,500,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to advance its minimally invasive brain interface platform already tested in 10 patients and accelerate development of a cortical foundation model for new BCIs.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Campus Biotech, Chemin des Mines 9
Geneva, 1202
Switzerland
Geneva, 1202
Switzerland
Phone
Undisclosed
Website
Email Address
Overview
Our Vision: To unleash human potential by harnessing the capabilities of Brain-Computer Interfaces. Our Mission: Building minimally invasive brain interfaces to monitor, treat, and restore lost functions for individuals fighting neurological disorders. We have pioneered the development of soft, elastic brain interfaces that offer enhanced bio-integration and minimize the mechanical mismatch with neural tissues.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Nicolas Vachicouras
Chief Technical Officer
Ludovic Serex
Co-Founder
Florian Fallegger
Co-Founder
Stéphanie Lacour
VP - Product Management
Alexandre Michalis
Browse more venture capital transactions:
Prev: 5/20/2026: Tribal venture capital transaction
Next: 5/20/2026: Novity venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs